Our fellowship-trained pathologists have decades of experience interpreting biopsies.
Danni Holanda, MD Nephropathologist
Dr. Danni Holanda joined Arkana Laboratory’s physician team in 2021. Dr. Holanda completed her MD at Universidade Federal do Ceará in Brazil and her pathology residency training at the University of Maryland Medical Center. She completed her renal pathology fellowship at Johns Hopkins University and a transplant pathology fellowship at the University of Pittsburgh Medical Center. Dr. Holanda comes to Arkana from the University of Iowa Carver College of Medicine where she was an associate professor, division head of renal pathology, and director of electron microscopy. Throughout her career, she has published multiple peer-reviewed articles and presented many invited lectures and grand rounds in the areas of medical renal pathology, transplant pathology, and genitourinary pathology. When not diagnosing kidney biopsies, Dr. Holanda enjoys spending time with family and doing “all things Mom”. When time allows, she is a curious artistic photography and literature learner and has fun contributing with a few vocal notes to a physician women’s amateur music band from her medical school.
Education & Stats
|Joined The Arkana Team||2021|
|Doctor of Medicine||Universidade Federal do Ceará, Brazil|
|Pathology Residency||University of Maryland Medical Center|
|Board Certification||American Board of Pathology|
|Renal Pathology Fellowship||Johns Hopkins University|
|Transplant Pathology Fellowship||University of Pittsburgh Medical Center|
Publications by Danni Holanda, M.D.
Persistent increase in mitochondrial superoxide mediates cisplatin-induced… Persistent increase in mitochondrial superoxide…
Severe and recurrent cisplatin-induced acute kidney injury (AKI) as part of standard cancer therapy is a known risk…
Severe and recurrent cisplatin-induced acute kidney injury (AKI) as part of standard cancer therapy is a known risk factor for development of chronic kidney disease (CKD).
Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case… Patient with a PRKAG2 mutation who developed…
PRKAG2 syndrome (PS) is a rare, early-onset autosomal dominant inherited disease caused by mutations in PRKAG2, the…
PRKAG2 syndrome (PS) is a rare, early-onset autosomal dominant inherited disease caused by mutations in PRKAG2, the gene encoding the regulatory γ2 subunit of adenosine monophosphate-activated protein kinase.
Sequential genetic testing of living related donors for inherited renal disease… Sequential genetic testing of living related…
Living kidney donors (LKDs) with a family history of renal disease are at risk of kidney disease as compared to LKDs…
Living kidney donors (LKDs) with a family history of renal disease are at risk of kidney disease as compared to LKDs without such history suggesting that some LKDs may be pre-symptomatic for monogenic kidney disease.